Loading company…
Oslo-based developer of an all-in-one point-of-care diagnostic platform for rapid near-patient testing.
Founded in 2012 in Oslo, Norway, Spinchip Diagnostics AS develops and produces an all-in-one point-of-care platform for rapid near-patient testing, sold to hospitals and clinics in Europe and North America. The company has completed five deals, and its latest was a trade sale in which bioMerieux paid NOK 1.62 billion on January 13, 2025. In 2023 it reported revenue of NOK 0 and an EBITDA loss of NOK 4,312,340.70.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in